DocGo Inc. Common Stock (DCGO) is a publicly traded Healthcare sector company. As of May 21, 2026, DCGO trades at $0.61 with a market cap of $54.59M and a P/E ratio of -0.33. DCGO moved +8.10% today. Year to date, DCGO is -31.33%; over the trailing twelve months it is -55.84%. Its 52-week range spans $0.49 to $5.68. Analyst consensus is buy with an average price target of $2.38. Rallies surfaces DCGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
DocGo Q1 2026 Revenue Up, Mobile Unit Challenges Pressure Margins: DocGo reported robust year-over-year revenue growth in Q1 2026 while highlighting operational challenges in mobile health unit deployments that pressured margins and cash flow. Management said it will implement routing and staffing efficiency initiatives to streamline operations and support anticipated demand.
| Metric | Value |
|---|---|
| Price | $0.61 |
| Market Cap | $54.59M |
| P/E Ratio | -0.33 |
| EPS | $-1.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.68 |
| 52-Week Low | $0.49 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $301.71M |
| Net Income | $-201.99M |
| Gross Margin | 0.00% |
5 analysts cover DCGO: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.38.